HeartSciences Named “Start-Up to Watch”
HeartSciences is delighted to have been highlighted as “Start-Up to Watch” in the June 8, 2018 issue of the MedTech Strategist . The article titled “HEARTSCIENCES: ARTIFICIAL INTELLIGENCE IMPROVES FRONTLINE RISK STRATIFICATION FOR HEART DISEASES ” discusses HeartSciences’ role in addressing the current challenges and significant unmet need to identify heart disease at an early stage and reduce the high prevalence of expensive diagnostic testing with low yields. The article highlights the enormous opportunity for HeartSciences’ breakthrough MyoVista® Wavelet ECG (wav ECG™) technology to benefit patients and to reduce health system costs and references a recently published study titled “Prediction of Abnormal Myocardial Relaxation From Signal Processed Surface ECG” in the Journal of American College of Cardiology (JACC ).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005088/en/
“It is an honor to be recognized by MedTech Strategist as a Start-Up to Watch,” said Mark Hilz, CEO. HeartSciences is working to bridge today’s “diagnostic gap” in cardiac care by providing low-cost effective solutions that help to identify patients prior to experiencing an adverse cardiac event, such as a heart attack.
“The current screening paradigm for heart disease is missing
people at early stages, when diseases are most treatable. HeartSciences
has taken a ubiquitous screening tool, the 12-lead ECG, and has, through
the application of signal processing and artificial intelligence, turned
it into a powerful tool that can detect diastolic dysfunction, an early
indicator of most cardiac diseases.”
--MedTech Strategist by Mary Stuart
HeartSciences is advancing the field of electrocardiography through the application of wavelet signal processing and artificial intelligence to develop next generation ECG technology. Wavelet signal processing is currently used in many different industries as an important tool to provide insights and new valuable data related to spectral analysis of a signal. HeartSciences’ MyoVista wav ECG Cardiac Testing Device is a 12-lead resting electrocardiograph utilizing continuous wavelet transform (CWT) based signal processing. Patented informatics focus on energy related information rather than conventional voltage-based information. HeartSciences’ mission is to enable accurate, affordable screening for the early detection of heart disease.
In addition to the proprietary informatics, the MyoVista wav ECG device also features the capabilities of a full featured 12-lead resting ECG including analysis using the Glasgow Algorithm, one of the world’s most respected interpretive algorithms. The device has a 15.6-inch high-resolution touchscreen display and incorporates many features commonly associated with a tablet device requiring minimal user training as well as easy and intuitive use. The MyoVista wav ECG device is not currently approved for sale or distribution in the United States and is not currently FDA cleared.
HeartSciences is a privately-held U.S. corporation based in Southlake, Texas.
For more information visit www.heartsciences.com .
The following link leads to a multimedia support platform designed to provide rapid download of media elements needed to develop your story about HeartSciences and MyoVista Technology.
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
CA-NEXON-AMERICA24.9.2018 19:02 | pressemeddelelse
Pre-Registration for MapleStory 2 Starts Today
CONCORDIA-UNIVERSITY24.9.2018 17:17 | pressemeddelelse
First Engineering Faculty in Canada Named after a Woman: Business Leader Gina Cody Makes Historic $15 Million Donation to Montreal’s Concordia University
CA-DOLE-FOOD-COMPANY-INC24.9.2018 17:02 | pressemeddelelse
Dole’s Standard Fruit Celebrates 20-Year Milestone as Environmental Leader
CITY-OF-HELSINKI24.9.2018 16:44 | pressemeddelelse
Helsinki Joins New York in Commitment to Review Local Progress Toward Global Sustainable Development Goals
TX-MAVENIR24.9.2018 15:02 | pressemeddelelse
Mavenir Wins 5G Asia “Best RAN Product” Award
ARTMS24.9.2018 15:02 | pressemeddelelse
ARTMS’ QUANTM Irradiation System™ to Be Featured at Two International Conferences in September
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum